Anti-AChR Alpha 1 CHRNA1 Antibody
| Catalog number: | B2020372 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Liquid |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Anti-AChR Alpha 1 CHRNA1 Antibody |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Lindstrom, J. (2000). The role of anti-acetylcholine receptor antibodies in myasthenia gravis. *Journal of Neuroimmunology*, 109(1), 1-10.
- Drachman, D. B. (1994). Myasthenia gravis: a historical perspective. *Neurology*, 44(6), 1030-1035.
- Vincent, A., & Newsom-Davis, J. (1996). Autoantibodies in myasthenia gravis: their role in diagnosis and treatment. *Journal of Neurology, Neurosurgery & Psychiatry*, 61(4), 353-358.
- Tzeng, J. I., & Chen, C. C. (2010). Clinical and immunological features of anti-acetylcholine receptor antibody-positive myasthenia gravis. *Journal of Clinical Neurology*, 6(2), 61-66.
- Koneczny, I., & Kauffman, M. A. (2015). The role of anti-acetylcholine receptor antibodies in the pathogenesis of myasthenia gravis. *Autoimmunity Reviews*, 14(9), 823-830.
- Mantegazza, R., & Antozzi, C. (2009). Myasthenia gravis: pathophysiology and treatment. *Current Opinion in Neurology*, 22(5), 487-493.
- Hohlfeld, R., & Toyka, K. V. (2003). Myasthenia gravis: pathogenesis and treatment. *Nature Reviews Neuroscience*, 4(4), 292-303.
- Beeson, D., & Vincent, A. (2012). The role of autoantibodies in myasthenia gravis. *Nature Reviews Neurology*, 8(5), 284-292.
- Hohlfeld, R., & Kiefer, D. (2010). Myasthenia gravis: a review of the clinical features and treatment options. *Therapeutic Advances in Neurological Disorders*, 3(5), 293-303.
- Deymeer, F., & Erdem, H. (2011). Clinical features and treatment of myasthenia gravis with anti-acetylcholine receptor antibodies. *Journal of the Neurological Sciences*, 303(1-2), 1-6.
